68Ga-DOTATOC Embolus Manifestation and Spontaneous Resolution by PET/CT

Akram Al-Ibraheem; Deya' Aldeen Sweedat; Farah Anwer; Feras Istatieh; Malik E Juweid

doi:10.1007/s13139-022-00752-8

⁶⁸Ga-DOTATOC Embolus Manifestation and Spontaneous Resolution by PET/CT

Nucl Med Mol Imaging. 2022 Aug;56(4):208-210. doi: 10.1007/s13139-022-00752-8. Epub 2022 May 12.

Authors

Akram Al-Ibraheem^{1

2}, Deya' Aldeen Sweedat¹, Farah Anwer^{1

3}, Feras Istatieh¹, Malik E Juweid²

Affiliations

¹ Department of Nuclear Medicine, King Hussein Cancer Center, P.O. Box 1269 Al-Jubeiha, Amman, 11941 Jordan.
² School of Medicine, The University of Jordan, Amman, Jordan.
³ Warith International Cancer Institute, Karbala, Iraq.

Abstract

⁶⁸Ga-labeled somatostatin receptor analogs physiologic distribution patterns have become recognizable among nuclear medicine physicians because of the increasing routine clinical use of this modality in the work-up of neuroendocrine tumors. Some pitfalls during ⁶⁸Ga-labeled somatostatin receptor PET/CT have recently been reported as causes of misdiagnoses. Iatrogenic microembolism as a cause of ¹⁸F-FDG embolus is well-established; however, 68Ga-DOTATOC embolus is not well documented in the literature. In the current case, the presence and the spontaneous resolution of the ⁶⁸Ga-labeled somatostatin receptor analogs embolus during sequential PET/CT are nicely demonstrated. Awareness of this incidental finding would avoid misdiagnosis and unnecessary investigations.

Keywords: 68Ga-labeled somatostatin receptor analogs; Embolus; PET/CT; Pulmonary microembolism.